GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | +3.4% | 11,809 | -2.1% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -42.0% | 12,064 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $50,000 | -67.7% | 12,064 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $155,000 | +19.2% | 12,064 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $130,000 | +18.2% | 12,064 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $110,000 | -12.7% | 12,064 | -9.4% | 0.01% | -20.0% |
| Q1 2021 | $126,000 | +12.5% | 13,314 | -53.1% | 0.01% | +11.1% |
| Q4 2020 | $112,000 | +28.7% | 28,380 | -13.3% | 0.01% | +12.5% |
| Q3 2020 | $87,000 | -64.0% | 32,740 | -10.0% | 0.01% | -68.0% |
| Q2 2020 | $242,000 | +160.2% | 36,390 | +127.0% | 0.02% | +127.3% |
| Q1 2020 | $93,000 | -35.4% | 16,030 | 0.0% | 0.01% | -26.7% |
| Q4 2019 | $144,000 | – | 16,030 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,005,894 | $43,264,000 | 17.91% |
| FRAZIER MANAGEMENT LLC | 4,667,242 | $50,406,000 | 4.03% |
| EcoR1 Capital, LLC | 5,560,748 | $60,056,000 | 2.09% |
| Palo Alto Investors LP | 2,356,282 | $25,448,000 | 1.54% |
| Avidity Partners Management LP | 4,457,831 | $48,145,000 | 1.07% |
| BVF INC/IL | 1,528,072 | $16,503,000 | 0.64% |
| Redmile Group, LLC | 2,821,085 | $30,468,000 | 0.53% |
| ACT CAPITAL MANAGEMENT, LLC | 74,000 | $799,000 | 0.41% |
| DG Capital Management, LLC | 83,162 | $898,000 | 0.18% |
| HighVista Strategies LLC | 14,453 | $156,000 | 0.10% |